Signed in as:
filler@godaddy.com
Pharma Portfolio Management Tool P2MT
This is our core tool for managing a portfolio of molecules or contracts.
mangage "molecule uncertainty"
How Does Molecule Uncertainty Affect You?
Start Ups
You are trying to allocate your limited resources to the best product /market combination that will allow you to grow and reach the next stage. Our Target Selection Tool will support you.
Pharma Companies
How will the molecule develop and what could be the impact on both volume and value? For small and mid sized companies, the Portfolio Management Tool provides a practical answer. For larger companies, although you often have the right resource, trying to build scenarios quicky can be frustratingly slow.
CDMOs, CROs and Other Service Providers
Our Portfolio Management Tool was originally developed for a CDMO. The CEO wanted to understand how his portfolio of over 200 molecules might develop over the next five years. The P2MT tool supports portfolio optimisation and risk management.
Finance Providers
You have a portfolio to maximise....do you have the right combination of risk and reward. How will molecules play out over the next five years?
Overview
We provide a suite of tools for growing and managing pharma companies. The tools focus on managing and optimising the life-cycle of the medicine. Pharma is one of the industries where long term planning and risk management are at a premium. We provide tools to support this. Portfolio optimisation, risk management, life-time value are the key elements.
We provide tools that are
- Are easy to set up and use
- Ensure the user understands the parameters
- Provides the basis for clear discussion and decision making at the Boardroom Level
Overview of Pharmagro Tools
Pharmagro Portfolio Management Tool P2MT
The P2MT allows users to manage and optimise their portfolios. It starts with easy data entry. The algorithm calculates life time value of the molecule and the associated risk. Phase risk is allocated according to the therapeutic category and phase number. Value and volume are forecast for the lifetime of the product. CEOs and CFOs can quickly see how the portfolio will develop in terms of value and volume. From there portfolio risk management can be executed.
We are in the testing phase and the tool will be fully available from August 2025. Contact us if you would like to test a beta version and receive a discount on the first year's subscription.
Sales Evaluation Tool
Quickly calculate the life-time value of your contract. Business Developers want to know where to place the effort that will get them to their targets. The tool links seemlessly to the Portfolio Tool so that sales leads and existing business can all be managed as one.
Target Selection Tool TST
Once the machine learning / AI assisted profiling has finished, you have to make a decision on which candidate molecules you will target for which diseases. The tool guides you through a decision path. There are four basic questions:
- Will the patient benefit?
- How convincing is the science?
- How strong is the molecule?
- Who will pay for it?
The TST is appropriate for Early Stage companies and Finance Providers
Sales & Operations Planning Tool
Once the business is up and running, the S&OP becomes an important control mechanism. We have adapted the Portfolio Management Tool to support S&OP. It provides a slightly longer term view and is a good complement to the monthly sales reporting and annual budgeting cycle.
Consulting
We provide consulting services on all of the above. Portfolio optimisation, risk management, S&OP. Contact us for an open discussion on how we can support you.